For more than a decade, PTC Therapeutics has been going back and forth with the FDA to find a path forward for a Duchenne muscular dystrophy drug with a spotty track record in clinical testing. That ...
The Averna ConnexThing Toolkits accelerate the deployment of IoT solutions with ThingWorx MONTREAL, Feb. 5, 2019 /PRNewswire/ -- Averna, a Test & Quality Solutions provider and PTC ThingWorx Platinum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results